{"transactions":[{"id":4614438,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":107961,"kind":"person","name":"Dash Barry H","position":1,"cik":"0001324222","reported_name":"Dash Barry H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-10T17:29:27.000Z","date":"2026-08-19","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":0.287,"value":8610.0,"ownership":{"direct":true},"balance_after":3265555,"source":{"system":"sec-edgar","filing":"0001324222-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1324222/000132422226000001/primary_doc.xml","form_type":"4"}},{"id":940330,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":69454,"kind":"person","name":"Plassche Douglas","position":1,"cik":"0001600946","reported_name":"Plassche Douglas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations"}}],"security":"Stock Options (right to buy)","published_at":"2026-01-13T21:35:20.000Z","date":"2026-01-09","kind":"exercise","planned":false,"acquired":false,"shares":2500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the stock options were fully vested and exercisable as of the transaction date."}],"balance_after":0,"derivative":{"exercise_price":0.03,"exercise_date":"2026-01-03","expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":2500000},"source":{"system":"sec-edgar","filing":"0001493152-26-002062","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000149315226002062/ownership.xml","form_type":"4"}},{"id":940329,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":69454,"kind":"person","name":"Plassche Douglas","position":1,"cik":"0001600946","reported_name":"Plassche Douglas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations"}}],"security":"Stock Options (right to buy)","published_at":"2026-01-13T21:35:20.000Z","date":"2026-01-09","kind":"exercise","planned":false,"acquired":true,"shares":2500000,"price":0.03,"value":75000.0,"ownership":{"direct":true},"balance_after":6000000,"source":{"system":"sec-edgar","filing":"0001493152-26-002062","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000149315226002062/ownership.xml","form_type":"4"}},{"id":1025296,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":69454,"kind":"person","name":"Plassche Douglas","position":1,"cik":"0001600946","reported_name":"Plassche Douglas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations"}}],"security":"common stock","published_at":"2025-10-04T01:58:48.000Z","date":"2025-10-02","kind":"sale","planned":false,"acquired":false,"shares":800000,"price":0.624,"value":499200.0,"ownership":{"direct":true},"balance_after":3500000,"source":{"system":"sec-edgar","filing":"0001493152-25-016979","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000149315225016979/ownership.xml","form_type":"4"}},{"id":1056035,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP","position":1,"cik":"0001053369","reported_name":"ELITE PHARMACEUTICALS INC /NV/","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations"}}],"security":"Stock Options (right to buy)","published_at":"2025-08-26T21:17:39.000Z","date":"2025-08-25","kind":"exercise","planned":false,"acquired":false,"shares":2500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the stock options were fully vested and exercisable as of the transaction date."}],"balance_after":2500000,"derivative":{"exercise_price":0.03,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":2500000},"source":{"system":"sec-edgar","filing":"0001493152-25-012347","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000149315225012347/ownership.xml","form_type":"4"}},{"id":1056034,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP","position":1,"cik":"0001053369","reported_name":"ELITE PHARMACEUTICALS INC /NV/","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations"}}],"security":"Common Stock","published_at":"2025-08-26T21:17:39.000Z","date":"2025-08-25","kind":"exercise","planned":false,"acquired":true,"shares":2500000,"price":0.03,"value":75000.0,"ownership":{"direct":true},"balance_after":4300000,"source":{"system":"sec-edgar","filing":"0001493152-25-012347","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000149315225012347/ownership.xml","form_type":"4"}},{"id":1056033,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP","position":1,"cik":"0001053369","reported_name":"ELITE PHARMACEUTICALS INC /NV/","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations"}}],"security":"Common Stock","published_at":"2025-08-26T21:17:39.000Z","date":"2025-08-22","kind":"sale","planned":false,"acquired":false,"shares":500000,"price":0.5243,"value":262150.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.52 to $0.56, inclusive. The reporting person undertakes to provide to Elite Phannaceuticals, any security holder of Elite Pharmaceuticals, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote(1) to this Form 4"}],"balance_after":1800000,"source":{"system":"sec-edgar","filing":"0001493152-25-012347","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000149315225012347/ownership.xml","form_type":"4"}},{"id":1081508,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":77231,"kind":"person","name":"Kirkov Kirko","position":1,"cik":"0001946043","reported_name":"Kirkov Kirko","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-07-25T22:05:07.000Z","date":"2025-07-10","kind":"purchase","planned":false,"acquired":true,"shares":16366,"price":0.589,"value":9639.574,"ownership":{"direct":true},"balance_after":16366,"source":{"system":"sec-edgar","filing":"0001946043-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000194604325000002/primary_doc.xml","form_type":"4"}},{"id":1089609,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":69454,"kind":"person","name":"Plassche Douglas","position":1,"cik":"0001600946","reported_name":"Plassche Douglas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations"}}],"security":"Stock Options (right to buy)","published_at":"2025-07-10T20:17:22.000Z","date":"2025-07-08","kind":"sale","planned":false,"acquired":false,"shares":200000,"price":0.579,"value":115800.0,"ownership":{"direct":true},"balance_after":2300000,"source":{"system":"sec-edgar","filing":"0001641172-25-018593","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000164117225018593/ownership.xml","form_type":"4"}},{"id":1090847,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":69454,"kind":"person","name":"Plassche Douglas","position":1,"cik":"0001600946","reported_name":"Plassche Douglas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations"}}],"security":"Stock Options (right to buy)","published_at":"2025-07-08T20:15:11.000Z","date":"2025-07-03","kind":"exercise","planned":false,"acquired":false,"shares":2500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the stock options were fully vested and exercisable as of the transaction date."}],"balance_after":5000000,"derivative":{"exercise_price":0.03,"exercise_date":"2025-01-03","expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":2500000},"source":{"system":"sec-edgar","filing":"0001641172-25-018199","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000164117225018199/ownership.xml","form_type":"4"}},{"id":1090846,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":69454,"kind":"person","name":"Plassche Douglas","position":1,"cik":"0001600946","reported_name":"Plassche Douglas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Operations"}}],"security":"Stock Options (right to buy)","published_at":"2025-07-08T20:15:11.000Z","date":"2025-07-03","kind":"exercise","planned":false,"acquired":true,"shares":2500000,"price":0.03,"value":75000.0,"ownership":{"direct":true},"balance_after":2500000,"source":{"system":"sec-edgar","filing":"0001641172-25-018199","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000164117225018199/ownership.xml","form_type":"4"}},{"id":1380797,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":69454,"kind":"person","name":"Plassche Douglas","position":1,"cik":"0001600946","reported_name":"Plassche Douglas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Operations"}}],"security":"Common Stock","published_at":"2024-10-28T21:23:07.000Z","date":"2024-10-24","kind":"sale","planned":false,"acquired":false,"shares":333932,"price":0.51,"value":170305.32,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001493152-24-042726","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000149315224042726/ownership.xml","form_type":"4"}},{"id":1380796,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":69454,"kind":"person","name":"Plassche Douglas","position":1,"cik":"0001600946","reported_name":"Plassche Douglas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Operations"}}],"security":"Common Stock","published_at":"2024-10-28T21:23:07.000Z","date":"2024-10-23","kind":"sale","planned":false,"acquired":false,"shares":800000,"price":0.49,"value":392000.0,"ownership":{"direct":true},"balance_after":333932,"source":{"system":"sec-edgar","filing":"0001493152-24-042726","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000149315224042726/ownership.xml","form_type":"4"}},{"id":1554411,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":92376,"kind":"person","name":"Hakim Nasrat A","position":1,"cik":"0001583742","reported_name":"Hakim Nasrat A","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO, President"}}],"security":"Common Stock","published_at":"2024-04-02T20:58:41.000Z","date":"2024-03-29","kind":"grant","planned":false,"acquired":true,"shares":49534368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued in settlement of compensation owed to the Reporting Person pursuant to his Employment Agreement with the issuer, dated August 1, 2013, as amended."}],"balance_after":216649250,"source":{"system":"sec-edgar","filing":"0001493152-24-012832","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000149315224012832/ownership.xml","form_type":"4"}},{"id":1698149,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":92376,"kind":"person","name":"Hakim Nasrat A","position":1,"cik":"0001583742","reported_name":"Hakim Nasrat A","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO, President"}}],"security":"Common Stock","published_at":"2023-12-29T19:21:28.000Z","date":"2023-12-29","kind":"grant","planned":false,"acquired":true,"shares":2223147,"price":0.069,"value":153397.143,"ownership":{"direct":false,"nature":"Kristine Hakim"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued in lieu of cash compensation for Pharmacovigilance and Medical Affairs consulting work during 2018-2022."}],"balance_after":2223147,"source":{"system":"sec-edgar","filing":"0001583742-23-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000158374223000001/primary_doc.xml","form_type":"4"}},{"id":1729767,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":107963,"kind":"person","name":"WHITNELL JEFFREY A","position":1,"cik":"0001126562","reported_name":"WHITNELL JEFFREY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-28T00:05:38.000Z","date":"2023-11-22","kind":"grant","planned":false,"acquired":true,"shares":547657,"price":0.0365,"value":19989.4805,"ownership":{"direct":true},"balance_after":3187020,"source":{"system":"sec-edgar","filing":"0001324222-23-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000132422223000003/primary_doc.xml","form_type":"4"}},{"id":1729766,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":107962,"kind":"person","name":"Caskey Davis S","position":1,"cik":"0001463732","reported_name":"Caskey Davis S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-27T23:58:46.000Z","date":"2023-11-22","kind":"grant","planned":false,"acquired":true,"shares":547657,"price":0.0365,"value":19989.4805,"ownership":{"direct":true},"balance_after":2049436,"source":{"system":"sec-edgar","filing":"0001324222-23-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000132422223000002/primary_doc.xml","form_type":"4"}},{"id":1729765,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":107961,"kind":"person","name":"Dash Barry H","position":1,"cik":"0001324222","reported_name":"Dash Barry H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-27T23:50:54.000Z","date":"2023-11-22","kind":"grant","planned":false,"acquired":true,"shares":547657,"price":0.0365,"value":19989.4805,"ownership":{"direct":true},"balance_after":3235555,"source":{"system":"sec-edgar","filing":"0001324222-23-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000132422223000001/primary_doc.xml","form_type":"4"}},{"id":1844508,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":69454,"kind":"person","name":"Plassche Douglas","position":1,"cik":"0001600946","reported_name":"Plassche Douglas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Operations"}}],"security":"Options","published_at":"2023-06-26T16:46:49.000Z","date":"2023-01-03","kind":"grant","planned":false,"acquired":true,"shares":7500000,"price":0.03,"value":225000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Options were awarded by the Board of Directions as part of Mr. Plassche's employment retention agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will best over a three-year period, commencing one year from the date of issuance. The first third will vest on January 3, 2024."}],"balance_after":7500000,"derivative":{"exercise_price":0.03,"exercise_date":"2024-01-03","expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":7500000},"source":{"system":"sec-edgar","filing":"0001600946-23-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000160094623000001/primary_doc.xml","form_type":"4"}},{"id":2118585,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":77231,"kind":"person","name":"Kirkov Kirko","position":1,"cik":"0001946043","reported_name":"Kirkov Kirko","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Options","published_at":"2022-11-14T16:10:33.000Z","date":"2022-09-06","kind":"grant","acquired":true,"shares":3000000,"price":0.035,"value":105000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Board of Directors approved and awarded options on November 10, 2022, as part of Mr. Kirkov's employment agreement dated September 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest over a three-year period, commencing one year from the date of issuance. The first third will vest on September 6, 2023."}],"balance_after":3000000,"derivative":{"exercise_price":0.035,"exercise_date":"2023-09-06","expiration_date":"2032-09-06","underlying":"Common Stock","underlying_shares":3000000},"source":{"system":"sec-edgar","filing":"0001946043-22-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000194604322000003/primary_doc.xml","form_type":"4"}},{"id":2172141,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":107963,"kind":"person","name":"WHITNELL JEFFREY A","position":1,"cik":"0001126562","reported_name":"WHITNELL JEFFREY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-29T17:49:17.000Z","date":"2022-08-28","kind":"grant","acquired":true,"shares":459536,"price":0.0435,"value":19989.816,"ownership":{"direct":true},"balance_after":2639363,"source":{"system":"sec-edgar","filing":"0001324222-22-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000132422222000003/primary_doc.xml","form_type":"4"}},{"id":2172140,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":107962,"kind":"person","name":"Caskey Davis S","position":1,"cik":"0001463732","reported_name":"Caskey Davis S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-29T17:40:45.000Z","date":"2022-08-28","kind":"grant","acquired":true,"shares":459536,"price":0.0435,"value":19989.816,"ownership":{"direct":true},"balance_after":1501779,"source":{"system":"sec-edgar","filing":"0001324222-22-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000132422222000002/primary_doc.xml","form_type":"4"}},{"id":2172139,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":107961,"kind":"person","name":"Dash Barry H","position":1,"cik":"0001324222","reported_name":"Dash Barry H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-29T17:35:48.000Z","date":"2022-08-28","kind":"grant","acquired":true,"shares":459536,"price":0.0435,"value":19989.816,"ownership":{"direct":true},"balance_after":2687898,"source":{"system":"sec-edgar","filing":"0001324222-22-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000132422222000001/primary_doc.xml","form_type":"4"}},{"id":2210982,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":125539,"kind":"person","name":"Chen Robert C J","position":1,"cik":"0001931826","reported_name":"Chen Robert C J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary, Treasurer"}}],"security":"Options","published_at":"2022-07-07T20:53:00.000Z","date":"2022-05-16","kind":"grant","acquired":true,"shares":900000,"price":0.04,"value":36000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Options were awarded by the Board of Directions as part of Mr. Chen's employment agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will best over a three-year period, commencing one year from the date of issuance. The first third will vest on May 16, 2023."}],"balance_after":900000,"derivative":{"exercise_price":0.04,"exercise_date":"2023-05-16","expiration_date":"2032-05-16","underlying":"Common Stock","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001931826-22-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000193182622000002/primary_doc.xml","form_type":"4"}},{"id":2639896,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":137534,"kind":"person","name":"Bregman Marc","position":1,"cik":"0001863113","reported_name":"Bregman Marc","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Secretary, Treasurer"}}],"security":"Options","published_at":"2021-07-07T21:00:33.000Z","date":"2021-05-17","kind":"grant","acquired":true,"shares":300000,"price":0.0562,"value":16860.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Options were awarded by the Board of Directors as part of Mr. Bregman's employment agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest over a three-year period, commencing one year from the date of issuance. The first third will vest on May 17, 2022"}],"balance_after":300000,"derivative":{"exercise_price":0.0562,"exercise_date":"2022-05-17","expiration_date":"2031-05-17","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001863113-21-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000186311321000002/primary_doc.xml","form_type":"4"}},{"id":2648359,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":107963,"kind":"person","name":"WHITNELL JEFFREY A","position":1,"cik":"0001126562","reported_name":"WHITNELL JEFFREY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T22:36:59.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":295570,"price":0.0677,"value":20010.089,"ownership":{"direct":true},"balance_after":2179827,"source":{"system":"sec-edgar","filing":"0001324222-21-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000132422221000003/primary_doc.xml","form_type":"4"}},{"id":2648358,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":107962,"kind":"person","name":"Caskey Davis S","position":1,"cik":"0001463732","reported_name":"Caskey Davis S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T22:30:42.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":295570,"price":0.0677,"value":20010.089,"ownership":{"direct":true},"balance_after":1042243,"source":{"system":"sec-edgar","filing":"0001324222-21-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000132422221000002/primary_doc.xml","form_type":"4"}},{"id":2648357,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":107961,"kind":"person","name":"Dash Barry H","position":1,"cik":"0001324222","reported_name":"Dash Barry H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T22:20:57.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":295570,"price":0.0677,"value":20010.089,"ownership":{"direct":true},"balance_after":2228182,"source":{"system":"sec-edgar","filing":"0001324222-21-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000132422221000001/primary_doc.xml","form_type":"4"}},{"id":3046749,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":92376,"kind":"person","name":"Hakim Nasrat A","position":1,"cik":"0001583742","reported_name":"Hakim Nasrat A","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & President"}}],"security":"Series J Convertible Preferred Shares","published_at":"2020-08-26T17:29:58.000Z","date":"2020-08-24","kind":"exercise","acquired":false,"shares":24.0344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The preferred shares are convertible into shares of common stock at a rate of 6,576,878.18 shares of common stock for each whole share of preferred stock, effectively $0.1521 per share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The preferred shares are convertible into shares of common stock at a rate of 6,576,878.18 shares of common stock for each whole share of preferred stock, effectively $0.1521 per share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shareholder Approval was obtained on June 23, 2020 for an increase in the number of authorized shares of common stock to permit full conversion of the preferred stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"None"}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":158017321},"source":{"system":"sec-edgar","filing":"0001583742-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000158374220000002/primary_doc.xml","form_type":"4"}},{"id":3046748,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":92376,"kind":"person","name":"Hakim Nasrat A","position":1,"cik":"0001583742","reported_name":"Hakim Nasrat A","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2020-08-26T17:29:58.000Z","date":"2020-08-24","kind":"exercise","acquired":true,"shares":158017321,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":167114882,"source":{"system":"sec-edgar","filing":"0001583742-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000158374220000002/primary_doc.xml","form_type":"4"}},{"id":3048990,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":69454,"kind":"person","name":"Plassche Douglas","position":1,"cik":"0001600946","reported_name":"Plassche Douglas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Operations"}}],"security":"Common Stock","published_at":"2020-08-24T18:24:18.000Z","date":"2020-08-20","kind":"grant","acquired":true,"shares":71739,"price":0.0876,"value":6284.3364,"ownership":{"direct":true},"balance_after":1133932,"source":{"system":"sec-edgar","filing":"0001324222-20-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000132422220000005/primary_doc.xml","form_type":"4"}},{"id":3048991,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":107962,"kind":"person","name":"Caskey Davis S","position":1,"cik":"0001463732","reported_name":"Caskey Davis S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-24T18:18:56.000Z","date":"2020-08-20","kind":"grant","acquired":true,"shares":516781,"price":0.0871,"value":45011.6251,"ownership":{"direct":true},"balance_after":746673,"source":{"system":"sec-edgar","filing":"0001324222-20-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000132422220000004/primary_doc.xml","form_type":"4"}},{"id":3048989,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":107963,"kind":"person","name":"WHITNELL JEFFREY A","position":1,"cik":"0001126562","reported_name":"WHITNELL JEFFREY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-24T18:15:05.000Z","date":"2020-08-20","kind":"grant","acquired":true,"shares":516781,"price":0.0871,"value":45011.6251,"ownership":{"direct":true},"balance_after":1884257,"source":{"system":"sec-edgar","filing":"0001324222-20-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000132422220000003/primary_doc.xml","form_type":"4"}},{"id":3048988,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":107961,"kind":"person","name":"Dash Barry H","position":1,"cik":"0001324222","reported_name":"Dash Barry H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-24T18:11:18.000Z","date":"2020-08-20","kind":"grant","acquired":true,"shares":516781,"price":0.0871,"value":45011.6251,"ownership":{"direct":true},"balance_after":1932612,"source":{"system":"sec-edgar","filing":"0001324222-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000132422220000002/primary_doc.xml","form_type":"4"}},{"id":3089327,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":69454,"kind":"person","name":"Plassche Douglas","position":1,"cik":"0001600946","reported_name":"Plassche Douglas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Operations"}}],"security":"Common Stock","published_at":"2020-07-06T15:38:28.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":574597,"price":0.087,"value":49989.939,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 2018 and 2019 salary shares"}],"balance_after":1062193,"source":{"system":"sec-edgar","filing":"0001600946-20-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000160094620000001/primary_doc.xml","form_type":"4"}},{"id":4031109,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":168950,"kind":"person","name":"Pfeifer Eugene M","position":1,"cik":"0001672351","reported_name":"Pfeifer Eugene M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-27T22:15:05.000Z","date":"2018-02-26","kind":"grant","acquired":true,"shares":161374,"price":0.1239,"value":19994.2386,"ownership":{"direct":true},"balance_after":233414,"source":{"system":"sec-edgar","filing":"0001053369-18-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000105336918000006/primary_doc.xml","form_type":"4"}},{"id":4031108,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":69454,"kind":"person","name":"Plassche Douglas","position":1,"cik":"0001600946","reported_name":"Plassche Douglas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Operations"}}],"security":"Common Stock","published_at":"2018-02-27T22:02:44.000Z","date":"2018-02-26","kind":"grant","acquired":true,"shares":201717,"price":0.1239,"value":24992.7363,"ownership":{"direct":true},"balance_after":487596,"source":{"system":"sec-edgar","filing":"0001053369-18-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000105336918000005/primary_doc.xml","form_type":"4"}},{"id":4031107,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":131121,"kind":"person","name":"Ward Carter Julian","position":1,"cik":"0001467874","reported_name":"Ward Carter Julian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Sec., Treas."}}],"security":"Common Stock","published_at":"2018-02-27T21:59:12.000Z","date":"2018-02-26","kind":"grant","acquired":true,"shares":242060,"price":0.1239,"value":29991.234,"ownership":{"direct":true},"balance_after":2127364,"source":{"system":"sec-edgar","filing":"0001053369-18-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000105336918000004/primary_doc.xml","form_type":"4"}},{"id":4031106,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":107963,"kind":"person","name":"WHITNELL JEFFREY A","position":1,"cik":"0001126562","reported_name":"WHITNELL JEFFREY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-27T21:53:28.000Z","date":"2018-02-26","kind":"grant","acquired":true,"shares":161374,"price":0.1239,"value":19994.2386,"ownership":{"direct":true},"balance_after":1367476,"source":{"system":"sec-edgar","filing":"0001053369-18-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000105336918000003/primary_doc.xml","form_type":"4"}},{"id":4031105,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":107961,"kind":"person","name":"Dash Barry H","position":1,"cik":"0001324222","reported_name":"Dash Barry H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-27T21:42:39.000Z","date":"2018-02-26","kind":"grant","acquired":true,"shares":161374,"price":0.1239,"value":19994.2386,"ownership":{"direct":true},"balance_after":1415831,"source":{"system":"sec-edgar","filing":"0001053369-18-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000105336918000002/primary_doc.xml","form_type":"4"}},{"id":4031104,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":107962,"kind":"person","name":"Caskey Davis S","position":1,"cik":"0001463732","reported_name":"Caskey Davis S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-27T21:37:19.000Z","date":"2018-02-26","kind":"grant","acquired":true,"shares":161374,"price":0.1239,"value":19994.2386,"ownership":{"direct":true},"balance_after":229892,"source":{"system":"sec-edgar","filing":"0001053369-18-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000105336918000001/primary_doc.xml","form_type":"4"}},{"id":4335735,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":92376,"kind":"person","name":"Hakim Nasrat A","position":1,"cik":"0001583742","reported_name":"Hakim Nasrat A","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & President"}}],"security":"Warrants","published_at":"2017-05-03T22:17:58.000Z","date":"2017-04-28","kind":"other","acquired":true,"shares":79008661,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The common shares were returned to the company in exchange for the Series J Convertible Preferred Shares and warrants issued by the company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The date that Shareholder Approval is obtained for an increase in the number of authorized shares of common stock to permit full conversion of the preferred stock and exercise of the warrants."}],"balance_after":79008661,"derivative":{"exercise_price":0.1521,"expiration_date":"2027-04-28","underlying":"Common Stock","underlying_shares":79008661},"source":{"system":"sec-edgar","filing":"0001583742-17-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000158374217000002/primary_doc.xml","form_type":"4"}},{"id":4335734,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":92376,"kind":"person","name":"Hakim Nasrat A","position":1,"cik":"0001583742","reported_name":"Hakim Nasrat A","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & President"}}],"security":"Series J Convertible Preferred Shares","published_at":"2017-05-03T22:17:58.000Z","date":"2017-04-28","kind":"other","acquired":true,"shares":24.0344,"price":1000000,"value":24034400.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The common shares were returned to the company in exchange for the Series J Convertible Preferred Shares and warrants issued by the company."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The common shares were returned to the company in exchange for the Series J Convertible Preferred Shares and warrants issued by the company."},{"field":"shares","element":"transactionShares","label":"F2","text":"The preferred shares are convertible into shares of common stock at a rate of 6,576,878.18 shares of common stock for each whole share of preferred stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The date that Shareholder Approval is obtained for an increase in the number of authorized shares of common stock to permit full conversion of the preferred stock and exercise of the warrants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"None."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The preferred shares are convertible into shares of common stock at a rate of 6,576,878.18 shares of common stock for each whole share of preferred stock."}],"balance_after":24.0344,"derivative":{"exercise_price":1000000,"underlying":"Common Stock","underlying_shares":158017321},"source":{"system":"sec-edgar","filing":"0001583742-17-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000158374217000002/primary_doc.xml","form_type":"4"}},{"id":4335733,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":92376,"kind":"person","name":"Hakim Nasrat A","position":1,"cik":"0001583742","reported_name":"Hakim Nasrat A","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2017-05-03T22:17:58.000Z","date":"2017-04-28","kind":"other","acquired":false,"shares":158017321,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The common shares were returned to the company in exchange for the Series J Convertible Preferred Shares and warrants issued by the company."},{"field":"shares","element":"transactionShares","label":"F1","text":"The common shares were returned to the company in exchange for the Series J Convertible Preferred Shares and warrants issued by the company."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common shares were returned to the company in exchange for the Series J Convertible Preferred Shares and warrants issued by the company."}],"balance_after":9097561,"source":{"system":"sec-edgar","filing":"0001583742-17-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000158374217000002/primary_doc.xml","form_type":"4"}},{"id":4422231,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":168950,"kind":"person","name":"Pfeifer Eugene M","position":1,"cik":"0001672351","reported_name":"Pfeifer Eugene M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-28T00:08:01.000Z","date":"2017-02-23","kind":"grant","acquired":true,"shares":72040,"price":0.2025,"value":14588.1,"ownership":{"direct":true},"balance_after":72040,"source":{"system":"sec-edgar","filing":"0001053369-17-000007","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000105336917000007/primary_doc.xml","form_type":"4"}},{"id":4422230,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":107962,"kind":"person","name":"Caskey Davis S","position":1,"cik":"0001463732","reported_name":"Caskey Davis S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-27T23:59:51.000Z","date":"2017-02-23","kind":"grant","acquired":true,"shares":68518,"price":0.1962,"value":13443.2316,"ownership":{"direct":true},"balance_after":68518,"source":{"system":"sec-edgar","filing":"0001053369-17-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000105336917000006/primary_doc.xml","form_type":"4"}},{"id":4422227,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":69454,"kind":"person","name":"Plassche Douglas","position":1,"cik":"0001600946","reported_name":"Plassche Douglas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Operations"}}],"security":"Common Stock","published_at":"2017-02-27T23:46:49.000Z","date":"2017-02-23","kind":"grant","acquired":true,"shares":110849,"price":0.2255,"value":24996.4495,"ownership":{"direct":true},"balance_after":285879,"source":{"system":"sec-edgar","filing":"0001053369-17-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000105336917000005/primary_doc.xml","form_type":"4"}},{"id":4422309,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":131121,"kind":"person","name":"Ward Carter Julian","position":1,"cik":"0001467874","reported_name":"Ward Carter Julian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-27T23:41:05.000Z","date":"2017-02-23","kind":"grant","acquired":true,"shares":133019,"price":0.2255,"value":29995.7845,"ownership":{"direct":true},"balance_after":1885304,"source":{"system":"sec-edgar","filing":"0001053369-17-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000105336917000004/primary_doc.xml","form_type":"4"}},{"id":4422225,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":107963,"kind":"person","name":"WHITNELL JEFFREY A","position":1,"cik":"0001126562","reported_name":"WHITNELL JEFFREY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-27T23:26:10.000Z","date":"2017-02-23","kind":"grant","acquired":true,"shares":88679,"price":0.2255,"value":19997.1145,"ownership":{"direct":true},"balance_after":1206102,"source":{"system":"sec-edgar","filing":"0001053369-17-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000105336917000003/primary_doc.xml","form_type":"4"}},{"id":4422223,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":107961,"kind":"person","name":"Dash Barry H","position":1,"cik":"0001324222","reported_name":"Dash Barry H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-27T23:17:47.000Z","date":"2017-02-23","kind":"grant","acquired":true,"shares":88679,"price":0.2255,"value":19997.1145,"ownership":{"direct":true},"balance_after":1254457,"source":{"system":"sec-edgar","filing":"0001053369-17-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000105336917000002/primary_doc.xml","form_type":"4"}},{"id":4422224,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":92376,"kind":"person","name":"Hakim Nasrat A","position":1,"cik":"0001583742","reported_name":"Hakim Nasrat A","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2017-02-27T23:09:54.000Z","date":"2017-02-23","kind":"grant","acquired":true,"shares":2216992,"price":0.2255,"value":499931.696,"ownership":{"direct":true},"balance_after":24143785,"source":{"system":"sec-edgar","filing":"0001053369-17-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000105336917000001/primary_doc.xml","form_type":"4"}}]}